UBS Maintains Buy on Life360, Lowers Price Target to $60

Benzinga Newsdesk www.benzinga.com Negative 68.5%

Neg 68.5% Neu 0% Pos 0%

UBS analyst Stephen Ju maintains Life360 (NASDAQ:LIF) with a Buy and lowers the price target from $64 to $60.

Comments

No comments yet. Be the first!